LIBRA THERAPEUTICS
Libra Therapeutics is a biotechnology company focused on developing novel disease-modifying therapeutics that can restore the cellular balance disrupted in neurodegenerative diseases.
LIBRA THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
2019-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.libratherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
29 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail GoDaddy DNS
Similar Organizations
AcureX Therapeutics
AcureX Therapeutics is a biotechnology company.
Adiposs
Adiposs SA is a clinical-stage life science company a first-in-class disruptive imaging product for cancer patients.
Arisan Therapeutics
Arisan Therapeutics is a life science company that develops novel solutions for the treatment of neglected and emerging infectious diseases.
Canadian Utilities
Canadian Utilities is a biotechnology company.
Cygnal Therapeutics
Cygnal Therapeutics is a biotechnology company
Danimer Scientific
Danimer Scientific is a biotechnology company that makes bioplastics used in disposable container coatings, packaging, and other products.
Disruptive Enterprises
Disruptive Enterprises is a health and wellness company.
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
Excellims Corporation
Excellims Corporation is a biotechnology company.
Faze Medicines
Faze Medicines is a biotechnology company.
Forkhead BioTherapeutics
Forkhead BioTherapeutics is a biotechnology company.
Geneius
Geneius is a Biotechnology company.
ImmuCision Biotherapeutics
ImmuCision Biotherapeutics, LLC, is a privately owned biotechnology company.
Immunicom
Immunicom is a biotechnology company.
In Diagnostics
In Diagnostics is a Biotechnology company
January Therapeutics
January Therapeutics is a San Diego-based biotechnology company.
Kankyo Daizen
Kankyo Daizen is a biotechnology company.
Lauren Sciences
Lauren Sciences is a Biotechnology Company.
Life Length
Life Length is a biotechnology company.
Neomorph
Neomorph is a biotechnology company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Neuroene Therapeutics
Neuroene Therapeutics is a startup biotechnology company.
NovAb
NovAb operates as a biotechnology company.
Overture Life
Overture Life is a biotechnology company
Primmune Therapeutics
Primmune Therapeutics is a Biotechnology company.
Recida Therapeutics
Recida Therapeutics is a Biotechnology company.
RNADerm Therapeutics
RNADerm Therapeutics is a biotechnology company.
RubrYc Therapeutics
RubrYc Therapeutics is a biotechnology company.
Savefruit
Savefruit is a biotechnology company.
Septerna
Septerna is a biotechnology company.
Seraxis
Seraxis is a privately owned biotechnology company.
Serionix
Serionix is a research and development company that develops materials for water and air purification.
Telum Therapeutics
Telum Therapeutics is a biotechnology company.
Tennessee Extracts
Tennessee Extracts is a biotechnology company.
TheraSource
TheraSource is a growing biotech company
Virokine Therapeutics
Virokine Therapeutics is a Biotechnology company.
XRad Therapeutics
XRad Therapeutics is a Biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Yonjin Venture
Yonjin Venture investment in Series A - Libra Therapeutics
Sante Ventures
Sante Ventures investment in Series A - Libra Therapeutics
Dolby Family Ventures
Dolby Family Ventures investment in Series A - Libra Therapeutics
Sixty Degree Capital
Sixty Degree Capital investment in Series A - Libra Therapeutics
Epidarex Capital
Epidarex Capital investment in Series A - Libra Therapeutics
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series A - Libra Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-19 | Libra Therapeutics Appoints Philip Lambert, Ph.D., as Chief Scientific Officer |
Official Site Inspections
http://www.libratherapeutics.com Semrush global rank: 3.7 M Semrush visits lastest month: 3.76 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Libra Therapeutics"
Libra Therapeutics
Chief Business Officer, Libra Therapeutics. Isaac Veinbergs, Ph.D., is the President and Chief Executive Officer at Libra Therapeutics, bringing over 25 years of experience in research and …See details»
Libra Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Libra Therapeutics is a biotechnology company focused on developing novel disease-modifying therapeutics that can restore the cellular …See details»
Libra Therapeutics
If you share a passion for neuroscience, drug discovery and ultimately, having a dramatic impact on improving patient lives or to apply for an open position, please email …See details»
Libra Therapeutics - Org Chart, Teams, Culture & Jobs | The Org
View Libra Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Libra Therapeutics - LinkedIn
Libra Therapeutics is focused on developing novel disease-modifying therapeutics that can restore the cellular balance disrupted in neurodegenerative diseases.See details»
Libra Therapeutics
Nov 1, 2024 The Company’s lead program targets TRPML1, a regulator of autophagy and lysosome function, and Libra is advancing additional small molecule programs for C9orf72 …See details»
Libra Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Last update 01 Nov 2024. Libra Therapeutics, Inc. Startups |See details»
Libra Therapeutics - Company Profile - Tracxn
Nov 30, 2024 Email ID: *****@libratherapeutics.com; Key Metrics. Total Funding. $29M in 1 round. Latest Funding Round. Series A, Sep 23, 2020, $29M. Investors. Boehringer Ingelheim …See details»
Libra Therapeutics Company Profile: Overview and Full News …
Libratherapeutics.com. Overview: Libra Therapeutics. Libra Therapeutics, based in California, is a biotechnology company dedicated to developing innovative therapeutics for …See details»
Libra Therapeutics - Overview, News & Similar companies
Oct 19, 2021 View Libra Therapeutics (www.libratherapeutics.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Axxam announces the launch of Libra Therapeutics to develop …
Axxam announces the launch of Libra Therapeutics to develop novel therapies targeting neurodegenerative diseases. Sept 24, 2020. Milan (Italy) – Axxam is proud to announce that …See details»
Libra Therapeutics - VentureRadar
Website: https://www.libratherapeutics.com/ Develops targeted small molecule therapies for neurodegenerative diseases, focusing on innovative treatments to improve ...See details»
Libra Therapeutics - Craft
Libra Therapeutics has 5 employees at their 1 location and $29 m in total funding,. See insights on Libra Therapeutics including office locations, competitors, revenue, financials, executives, …See details»
Libra Therapeutics Information - RocketReach
Libratherapeutics.com; Martin Gill Vice-President and Head of Biology at Libra Therapeutics San Diego, CA, US View. 3 libratherapeutics.com; gmail.com; ajaugur.com; 1 619840XXXX; View …See details»
Libra Therapeutics Launches with $29 Million Series A to Develop …
Sep 23, 2020 Libra Therapeutics was founded on breakthrough science generated by Axxam S.p.A., a leading discovery research organization, which provides Libra Therapeutics novel …See details»
Epidarex Capital Co-leads $29 Million Series A Financing in Newly ...
Sep 23, 2020 Libra Therapeutics is developing novel therapeutics for neurodegenerative diseases. BETHESDA, MD (US) and EDINBURGH (UK), September 23, 2020 – Epidarex …See details»
Libra Therapeutics - PitchBook
Libra Therapeutics General Information Description. Developer of novel disease-modifying therapeutics intended to restore the cellular balance disrupted in neurodegenerative diseases.See details»
Libra Raises $29 Million to Tackle Neurodegenerative Diseases
Sep 24, 2020 Libra’s breakthrough science comes from leading Italian discovery organization, Axxam S.p.A., which provides proprietary chemical matter, cutting edge assays and drug …See details»
Libra Therapeutics
SAN DIEGO, March 9, 2022 – Libra Therapeutics, Inc., a private biotech developing novel therapeutics to restore cellular balance and stop neurodegeneration, today announced the …See details»
Libra Therapeutics - VentureRadar
Similar Companies: Muna Therapeutics Denmark Privately Held Muna Therapeutics is a private biopharmaceutical company founded in 2020 and based in Copenhagen, Denmark and …See details»